🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Aurora A kinase inhibitor MLN8237 may stop the growth of tumor c...
Status
Terminated
Location
Vanderbilt-Ingram Cancer Center
Start Date
2011-10
Trial ID
NCT01316692
This phase II trial studies how well alisertib with or without fulvestrant ...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2017-07-06
Trial ID
NCT02860000
Treatments Being Tested
The goal of this clinical trial is to learn if alisertib in addition to usu...
Status
Not Yet Recruiting
Location
University of Wisconsin Carbone Cancer Center
Start Date
2026-09
Trial ID
NCT07706179
Treatments Being Tested
Objectives: Objectives The primary objective of this study is to: To ass...
Status
Completed
Location
University of Texas MD Anderson Cancer Center
Start Date
2015-05-20
Trial ID
NCT02293005
Treatments Being Tested
The goal of this clinical research study is to learn if the study drug, ali...
Status
Completed
Location
22 Sites
Start Date
2015-02-12
Trial ID
NCT02187991
Treatments Being Tested
This research study is studying a targeted therapy (a form of treatment tha...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2015-12
Trial ID
NCT02560025
Treatments Being Tested
The purpose of this study is to evaluate the anti-tumor activity of alisert...
Status
Completed
Location
Hematology Oncology Associates, Virtua Memorial Hospital Burlington County
Start Date
2009-02-10
Trial ID
NCT00807495
Treatments Being Tested
This phase I trial studies the side effects and the best dose of alisertib ...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2012-04-16
Trial ID
NCT01567709
Treatments Being Tested
The goal of the first part of this clinical trial (Phase I portion) is to s...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2012-05
Trial ID
NCT01601535
Treatments Being Tested
RATIONALE: MLN8237 may stop the growth of cancer cells by blocking some of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-09
Trial ID
NCT02444884
Treatments Being Tested